BusinessGeron to Present at the RBC Capital Markets Healthcare ConferenceBy Nasdaq OMXFeb 10, 2016, 12:30 PM UTC
BusinessGeron Announces Initiation of Janssen Phase 2/3 Clinical Trial of Imetelstat in Myelodysplastic SyndromesBy Nasdaq OMXJan 14, 2016, 12:30 PM UTC
BusinessGeron Announces December Conference Presentation WebcastsBy Nasdaq OMXNov 30, 2015, 12:30 PM UTC